TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
29 hedge funds and large institutions have $1.39M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 6 closing their positions.
Holders
29
Holders Change
+5
Holders Change %
+20.83%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
3
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
LPL Financial
San Diego,
California
|
$194K |
| 2 |
2
Renaissance Technologies
New York
|
$129K |
| 3 |
3
Jane Street
New York
|
$78.4K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$39.3K |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$123K |
Top Sellers
| 1 |
IC
1
Ikarian Capital
Dallas,
Texas
|
$0 |
| 2 |
2
Millennium Management
New York
|
$32.1K |
| 3 |
BFM
3
Boothbay Fund Management
New York
|
$0 |
| 4 |
4
Squarepoint
New York
|
$167K |
| 5 |
GS
5
GTS Securities
New York
|
$0 |
